Global Novel Oral AntiCoagulants (NOAC) Market Analysis 2013-2018 and Forecast 2019-2024

Table of Contents

1 Industry Overview

• 1.1 Novel Oral AntiCoagulants (NOAC) Industry
  • 1.1.1 Overview
  • 1.1.2 Development of Novel Oral AntiCoagulants (NOAC)
• 1.2 Market Segment
  • 1.2.1 Upstream
  • 1.2.2 Downstream
• 1.3 Cost Analysis

2 Industry Environment (PEST Analysis)

• 2.1 Policy
• 2.2 Economics
• 2.3 Sociology
• 2.4 Technology

3 Novel Oral AntiCoagulants (NOAC) Market by Type

• 3.1 By Type
  • 3.1.1 Direct Thrombin Inhibitors
  • 3.1.2 Direct Factor Xa Inhibitors
• 3.2 Market Size
• 3.3 Market Forecast

4 Major Companies List

4.Novel Oral AntiCoagulants (NOAC) Johnson & Johnson (Company Profile, Sales Data etc.)

• 4.2 Bristol-Myers Squibb (Company Profile, Sales Data etc.)
• 4.3 Boehringer Ingelheim (Company Profile, Sales Data etc.)
• 4.4 Sanofi (Company Profile, Sales Data etc.)
• 4.5 Daiichi Sankyo (Company Profile, Sales Data etc.)
• 4.6 Armatheon (Company Profile, Sales Data etc.)
• 4.7 Aspen (Company Profile, Sales Data etc.)
• 4.8 AstraZeneca (Company Profile, Sales Data etc.)
• 4.9 Bayer (Company Profile, Sales Data etc.)
• 4.10 Cellceutix (Company Profile, Sales Data etc.)
• 4.11 Cosmo Pharmaceuticals (Company Profile, Sales Data etc.)
• 4.12 CSL Behring (Company Profile, Sales Data etc.)
• 4.13 Eisai (Company Profile, Sales Data etc.)
• 4.14 GSK (Company Profile, Sales Data etc.)
• 4.15 Marathon Pharmaceuticals (Company Profile, Sales Data etc.)
• 4.16 Ockham Biotech (Company Profile, Sales Data etc.)
• 4.17 Perosphere (Company Profile, Sales Data etc.)

5 Market Competition

• 5.1 Company Competition
• 5.2 Regional Market by Company

6 Demand by End Market

• 6.1 Demand Situation
  • 6.1.1 Demand in Deep Vein Thrombosis (DVT)
  • 6.1.2 Demand in Pulmonary Embolism
  • 6.1.3 Demand in Acute Coronary Syndrome
  • 6.1.4 Demand in Hemodialysis
  • 6.1.5 Demand in Others
• 6.2 Regional Demand Comparison
• 6.3 Demand Forecast

7 Region Operation

• 7.1 Regional Production
• 7.2 Regional Market
• 7.3 by Region
  • 7.3.1 North America
    • 7.3.1.1 Overview
    • 7.3.1.2 by Country (U.S., Canada, Mexico)
  • 7.3.2 Europe
    • 7.3.2.1 Overview
    • 7.3.2.2 by Country (Germany, U.K., France, Italy, Russia, Spain etc.)
  • 7.3.3 Asia-Pacific
    • 7.3.3.1 Overview
    • 7.3.3.2 by Country (China, India, Japan, Southeast Asia etc.)
  • 7.3.4 South America
    • 7.3.4.1 Overview
    • 7.3.4.2 by Country (Brazil, Argentina etc.)
  • 7.3.5 Middle East & Africa
    • 7.3.5.1 Overview
    • 7.3.5.2 by Country (Saudi Arabia, South Africa etc.)
• 7.4 Regional Import & Export
• 7.5 Regional Forecast

8 Marketing & Price

• 8.1 Price and Margin
  • 8.1.1 Price Trends
  • 8.1.2 Factors of Price Change
  • 8.1.3 Manufacturers Gross Margin Analysis
• 8.2 Marketing Channel

9 Research Conclusion

List of Tables

Table Upstream Segment of Novel Oral AntiCoagulants (NOAC)

Table Application Segment of Novel Oral AntiCoagulants (NOAC)

Table Global Novel Oral AntiCoagulants (NOAC) Market 2013-2024, by Application, in USD Million

Table Major Company List of Direct Thrombin Inhibitors

Table Major Company List of Direct Factor Xa Inhibitors

Table Global Novel Oral AntiCoagulants (NOAC) Market 2013-2018, by Type, in USD Million

Table Global Novel Oral AntiCoagulants (NOAC) Market 2013-2018, by Type, in Volume

Table Global Novel Oral AntiCoagulants (NOAC) Market Forecast 2019-2024, by Type, in USD Million

Table Global Novel Oral AntiCoagulants (NOAC) Market Forecast 2019-2024, by Type, in Volume

Table Johnson & Johnson Overview List

Table Novel Oral AntiCoagulants (NOAC) Business Operation of Johnson & Johnson (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Bristol-Myers Squibb Overview List

Table Novel Oral AntiCoagulants (NOAC) Business Operation of Bristol-Myers Squibb (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Boehringer Ingelheim Overview List

Table Novel Oral AntiCoagulants (NOAC) Business Operation of Boehringer Ingelheim (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Sanofi Overview List

Table Novel Oral AntiCoagulants (NOAC) Business Operation of Sanofi (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Daiichi Sankyo Overview List

Table Novel Oral AntiCoagulants (NOAC) Business Operation of Daiichi Sankyo (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Armatheon Overview List

Table Novel Oral AntiCoagulants (NOAC) Business Operation of Armatheon (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Aspen Overview List

Table Novel Oral AntiCoagulants (NOAC) Business Operation of Aspen (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table AstraZeneca Overview List

Table Novel Oral AntiCoagulants (NOAC) Business Operation of AstraZeneca (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Bayer Overview List

Table Novel Oral AntiCoagulants (NOAC) Business Operation of Bayer (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Cellceutix Overview List

Table Novel Oral AntiCoagulants (NOAC) Business Operation of Cellceutix (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Cosmo Pharmaceuticals Overview List

Table Novel Oral AntiCoagulants (NOAC) Business Operation of Cosmo Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table CSL Behring Overview List

Table Novel Oral AntiCoagulants (NOAC) Business Operation of CSL Behring (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Eisai Overview List

Table Novel Oral AntiCoagulants (NOAC) Business Operation of Eisai (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table GSK Overview List

Table Novel Oral AntiCoagulants (NOAC) Business Operation of GSK (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Marathon Pharmaceuticals Overview List

Table Novel Oral AntiCoagulants (NOAC) Business Operation of Marathon Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Ockham Biotech Overview List

Table Novel Oral AntiCoagulants (NOAC) Business Operation of Ockham Biotech (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Perosphere Overview List

Table Novel Oral AntiCoagulants (NOAC) Business Operation of Perosphere (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Global Novel Oral AntiCoagulants (NOAC) Sales Revenue 2013-2018, by Company, in USD Million

Table Global Novel Oral AntiCoagulants (NOAC) Sales Revenue Share, by Company, in USD Million

Table Global Novel Oral AntiCoagulants (NOAC) Sales Volume 2013-2018, by Company, in Volume

Table Global Novel Oral AntiCoagulants (NOAC) Sales Volume Share 2013-2018, by Company, in Volume

Table Major Consumers List and Overview

Table Regional Demand Comparison List

Table Major Application in Different Regions

Table Novel Oral AntiCoagulants (NOAC) Demand Forecast 2019-2024, by Application, in USD Million

Table Novel Oral AntiCoagulants (NOAC) Demand Forecast 2019-2024, by Application, in Volume

Table Novel Oral AntiCoagulants (NOAC) Production 2013-2018, by Region, in USD Million

Table Novel Oral AntiCoagulants (NOAC) Production 2013-2018, by Region, in Volume

Table Global Novel Oral AntiCoagulants (NOAC) Market 2013-2018, by Region, in USD Million

Table Global Novel Oral AntiCoagulants (NOAC) Market Share 2013-2018, by Region, in USD Million

Table Global Novel Oral AntiCoagulants (NOAC) Market 2013-2018, by Region, in Volume

Table Global Novel Oral AntiCoagulants (NOAC) Market Share 2013-2018, by Region, in Volume

Table North America Novel Oral AntiCoagulants (NOAC) Market Size 2013-2018, by Country, in USD Million

Table North America Novel Oral AntiCoagulants (NOAC) Market Size 2013-2018, by Country, in Volume

Table Europe Novel Oral AntiCoagulants (NOAC) Market Size 2013-2018, by Country, in USD Million

Table Europe Novel Oral AntiCoagulants (NOAC) Market Size 2013-2018, by Country, in Volume

Table Asia-Pacific Novel Oral AntiCoagulants (NOAC) Market Size 2013-2018, by Country, in USD Million

Table Asia-Pacific Novel Oral AntiCoagulants (NOAC) Market Size 2013-2018, by Country, in Volume

Table South America Novel Oral AntiCoagulants (NOAC) Market Size 2013-2018, by Country, in USD Million

Table South America Novel Oral AntiCoagulants (NOAC) Market Size 2013-2018, by Country, in Volume

Table Middle East & Africa Novel Oral AntiCoagulants (NOAC) Market Size 2013-2018, by Country, in USD Million

Table Middle East & Africa Novel Oral AntiCoagulants (NOAC) Market Size 2013-2018, by Country, in Volume

Table Novel Oral AntiCoagulants (NOAC) Market Forecast 2019-2024, by Region, in USD Million

Table Novel Oral AntiCoagulants (NOAC) Market Forecast 2019-2024, by Region, in Volume

Table Price Factors List

List of Figures

Figure Global Novel Oral AntiCoagulants (NOAC) Market Growth 2013-2018, by Type, in USD Million

Figure Global Novel Oral AntiCoagulants (NOAC) Market Growth 2013-2018, by Type, in Volume

Figure North America Novel Oral AntiCoagulants (NOAC) Market Concentration, in 2018

Figure Europe Novel Oral AntiCoagulants (NOAC) Market Market Concentration, in 2018

Figure Asia-Pacific Novel Oral AntiCoagulants (NOAC) MMarket Concentration, in 2018

Figure South America Novel Oral AntiCoagulants (NOAC) Market Concentration, in 2018

Figure Middle East & Africa Novel Oral AntiCoagulants (NOAC) Market Concentration, in 2018

Figure Novel Oral AntiCoagulants (NOAC) Demand in Deep Vein Thrombosis (DVT), 2013-2018, in USD Million

Figure Novel Oral AntiCoagulants (NOAC) Demand in Deep Vein Thrombosis (DVT), 2013-2018, in Volume

Figure Novel Oral AntiCoagulants (NOAC) Demand in Pulmonary Embolism, 2013-2018, in USD Million

Figure Novel Oral AntiCoagulants (NOAC) Demand in Pulmonary Embolism, 2013-2018, in Volume

Figure Novel Oral AntiCoagulants (NOAC) Demand in Acute Coronary Syndrome, 2013-2018, in USD Million

Figure Novel Oral AntiCoagulants (NOAC) Demand in Acute Coronary Syndrome, 2013-2018, in Volume

Figure Novel Oral AntiCoagulants (NOAC) Demand in Hemodialysis, 2013-2018, in USD Million

Figure Novel Oral AntiCoagulants (NOAC) Demand in Hemodialysis, 2013-2018, in Volume

Figure Novel Oral AntiCoagulants (NOAC) Demand in Others, 2013-2018, in USD Million

Figure Novel Oral AntiCoagulants (NOAC) Demand in Others, 2013-2018, in Volume

Figure North America Novel Oral AntiCoagulants (NOAC) Market Size and Growth 2013-2018, in USD Million

Figure North America Novel Oral AntiCoagulants (NOAC) Market Size and Growth 2013-2018, in Volume

Figure Europe Novel Oral AntiCoagulants (NOAC) Market Size and Growth 2013-2018, in USD Million

Figure Europe Novel Oral AntiCoagulants (NOAC) Market Size and Growth 2013-2018, in Volume

Figure Asia-Pacific Novel Oral AntiCoagulants (NOAC) Market Size and Growth 2013-2018, in USD Million

Figure Asia-Pacific Novel Oral AntiCoagulants (NOAC) Market Size and Growth 2013-2018, in Volume

Figure South America Novel Oral AntiCoagulants (NOAC) Market Size and Growth 2013-2018, in USD Million

Figure South America Novel Oral AntiCoagulants (NOAC) Market Size and Growth 2013-2018, in Volume

Figure Middle East & Africa Novel Oral AntiCoagulants (NOAC) Market Size and Growth 2013-2018, in USD Million

Figure Middle East & Africa Novel Oral AntiCoagulants (NOAC) Market Size and Growth 2013-2018, in Volume

Figure Marketing Channels Overview